Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1Other 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 805Uterine Cervical Neoplasms 409Fallopian Tube Neoplasms 289Endometrial Neoplasms 287Carcinoma, Ovarian Epithelial 252Neoplasms 95Recurrence 83Breast Neoplasms 82Peritoneal Neoplasms 66Uterine Neoplasms 55Colorectal Neoplasms 54Uterine Cervical Dysplasia 50Sarcoma 49Vulvar Neoplasms 47Neoplasm Metastasis 44Carcinoma, Non-Small-Cell Lung 44Stomach Neoplasms 42Pancreatic Neoplasms 36Melanoma 34Testicular Neoplasms 32Lung Neoplasms 32Vaginal Neoplasms 28Prostatic Neoplasms 28Papillomavirus Infections 25Carcinoma 25Head and Neck Neoplasms 23Esophageal Neoplasms 23Carcinoma, Renal Cell 23Urinary Bladder Neoplasms 21Small Cell Lung Carcinoma 21

Interventions

Octreotide 2Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Intestinal Obstruction × Gynecologic × Clear all
NCT00004895 2012-06-06

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Northwestern University

Phase 2 Completed
GastrointestinalGynecologicOtherSarcoma

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Colonic Neoplasms, Constipation, Intestinal Obstruction, Nausea, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT00332696 2011-09-23

Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis

Novartis

Phase 2 Completed
64 enrolled 17 charts
Gynecologic

Carcinoma, Intestinal Obstruction, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡